BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$23.13 USD
+0.25 (1.09%)
Updated Aug 7, 2024 09:44 AM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 41 - 60 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Beat and Raise Highlight Cell & Gene Strength
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Buy Shares on Weakness; Positive Industry Dynamics, RGEN, CYRX, and CTLT Read-Throughs
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Inaugural Life Sciences & MedTech Conference: Key Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Inaugural KBCM Life Sciences & MedTech Forum: Day 1 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
4Q Beat and Biologic Expansion with Stirling Acquisition
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Life Science Tools: DC Never Friendlier with Biden "American Rescue Plan"
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
D.C. Very Friendly with Biden "American Rescue Plan";
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Initiating Coverage at Overweight: Cell - Gene Therapy Tool Pure Play
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Restatements Completed; 1Q20 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Preliminary 1Q20 Revenue Beats Forecast; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R